This is a phase 2, single-arm, open-label clinical trial determining efficacy of Epcoritamab in subjects with Chronic Lymphocytic Leukemia (CLL) on Burton Tyro…

CLLCLL (Chronic Lymphocytic Leukemia)Chronic Lymphocytic Leukemia (CLL)+1 more

~Estimated

~$10 – $6,250

University of California, IrvineNCT07819214

Phase 2

Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study

to learn if giving glofitamab after treatment with BTKi-rituximab can help to control high-risk MCL.

Phase 2 StudyMCLBTKi+2 more

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT07257055